ORPHAZYME A/S  DK 1
ORPHAZYME A/S DK 1
Aktie · DK0060910917 · A2H7EV (XCSE)
Übersicht Finanzkennzahlen
Kein Kurs
n/a

Aktuelle Kurse von ORPHAZYME A/S DK 1

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XLON: London
London
0CUM.L
DKK
27.09.2023 09:07
0,99 DKK
0,00 DKK

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,06 % 0,07 % - - 131.412,69 % 131.453,78 % 824,95 %

Firmenprofil zu ORPHAZYME A/S DK 1 Aktie

Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative rare diseases. The company offers heat stock proteins that focuses on the treatment of neurodegenerative diseases by harnessing the cell protective properties of the heat shock response, which protects cells from the accumulation of misfolded proteins, aggregated proteins, and dysfunctional lysosomes. Its lead candidate is the Arimoclomol, which is in clinical development for diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, and Inclusion Body Myositis. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.

Unternehmensdaten

Name ORPHAZYME A/S DK 1
Firma Orphazyme A/S
Website https://www.orphazyme.com
Heimatbörse XCSE NASDAQ COPENHAGEN A/S
WKN A2H7EV
ISIN DK0060910917
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Pharmaceuticals
CEO Mr. Jakob Færch Bendtsen
Land Dänemark
Währung EUR
Mitarbeiter 0,0 T
Adresse Ole MaalOees Vej 3, 2200 Copenhagen
IPO Datum 2018-02-12

Stock Splits

Date Split
06.12.2023 1:1000

Ticker Symbols

Name Symbol
London 0CUM.L

More Shares

Investors who ORPHAZYME A/S DK 1 hold also have the following shares in their portfolio:
COOP-GRUPPE GENOSSE.16-26
COOP-GRUPPE GENOSSE.16-26 Bond
IS.MSCI W.E-U.E DLA
IS.MSCI W.E-U.E DLA ETF
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025